Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement
White paper exploring the IRA’s small but measurable impact in several key areas
Certara2024 年 8 月 13 日
All you need to know about NCI, CDISC and SDTM controlled terminology
The use of controlled terminology (CT) is vital to successful clinical study build. In clinical…
Certara2024 年 8 月 13 日
Digital Payer Portals for Enhanced Value Communication
The trend of using digital tools for communication and information sharing in the life science…
Certara2024 年 8 月 9 日
Certara’s MIDD Oncology Capabilities
Improve Oncology Study Decisions with Certara's MIDD Team Transcript: The pace of oncology drug…
Certara2024 年 8 月 7 日
A quick guide to implementing a Clinical MDR
Read our free guide to learn the three-step best practice process to implementing a Clinical…
Certara2024 年 8 月 7 日
Certara Reports Second Quarter 2024 Financial Results
Reiterates Full Year 2024 Financial Guidance RADNOR, PA — August 6, 2024-- Certara, Inc. （纳斯达克股票代码：CERT),…
Certara2024 年 8 月 6 日
Certara Talks: PAGE 2024
Learn more about our Modeling & Simulation Services Transcript: Hello, and welcome to Certara…
Certara2024 年 8 月 5 日
Certara’s AI Answer to Medical Writing Challenges in Pharma
Medical writing is a complex and regulated process that requires compliance with guidelines from health…
Certara2024 年 7 月 30 日
